ATACC
Dead / Abandoned — Abandoned — failure to respond (as of 17 Jan 2019)
What this means for you
This application is over — abandoned 24 Dec 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87818646
- Mark type
- Word mark
- Filed
- 02 Mar 2018
- Abandoned
- 24 Dec 2018
- Attorney of record
- Alex Patel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-diabetic pharmaceuticals; Anti-cancer preparations; Cellular function activating agents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Owner
- Phanes Therapeutics,Inc., SAN DIEGO, CA, US
Prosecution history
- 17 Jan 2019 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 17 Jan 2019 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 21 Jun 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jun 2018 — NON-FINAL ACTION E-MAILED
- 21 Jun 2018 — NON-FINAL ACTION WRITTEN
- 14 Jun 2018 — ASSIGNED TO EXAMINER
- 09 Mar 2018 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Mar 2018 — NEW APPLICATION ENTERED